SREBF1 and hydrops fetalis: In particular, 40 mg/kg b.w./day phyllodulcin supplementation markedly suppressed expression of C/EBPα by 72.7% (p < 0.01), PPARγ by 78.7% (p < 0.001), and SREBP-1c by 93.6% (p < 0.001) compared to the HF group.